What is Getlabs?
Founded in 2018 and based in Santa Monica, CA, Getlabs offers a convenient solution for patients needing laboratory tests. The company dispatches certified phlebotomists to customer locations to collect samples for major diagnostic providers like Labcorp and Quest Diagnostics. This model addresses accessibility challenges in healthcare, enabling individuals to fulfill their medical testing requirements without visiting a clinic.
How much funding has Getlabs raised?
Getlabs has raised a total of $23M across 2 funding rounds:
Angel/Seed
$3M
Series A
$20M
Angel/Seed (2021): $3M with participation from PivotNorth Capital
Series A (2022): $20M led by Emerson Collective and The Minderoo Foundation
Key Investors in Getlabs
PivotNorth Capital
Pivot North Capital is a venture capital firm that focuses on early-stage technology companies, providing funding and strategic support to innovative startups. They aim to foster growth and development in the technology sector.
Emerson Collective
Emerson Collective invests in entrepreneurs and innovators focused on creating a world that expands opportunity and ensures human flourishing, addressing complex challenges in education, economic mobility, immigration, and the environment.
The Minderoo Foundation
The Minderoo Foundation is a philanthropic organisation seeking to drive positive, lasting change through initiatives in ocean research, ending slavery, cancer collaboration, and community projects.
What's next for Getlabs?
The recent major strategic investment, following a prior Seed/Angel round, indicates Getlabs is poised for significant scaling and market expansion. This capital infusion is likely to fuel enhancements in operational infrastructure, phlebotomist network growth, and broader service area coverage. The company's focus on streamlining the lab testing process positions it to capture a larger share of the growing telehealth and remote patient monitoring markets.
See full Getlabs company page
